Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

BJUI compass

Showing results (331-340 of 642) with videos related to

Pageof 65
Sort By:
BJUI Compass|February 19, 2024
Reliability of the IDENTIFY calculator in stratifying risk of urothelial carcinoma in patients with haematuria: An initial evaluation at an Australian centrePaul M Rival, Lucas Ooi, Hyun Lim, et al.
BJUI Compass|April 27, 2022
Bladder cancer biomarkers: Past and future directionsMiguel Rodriguez-Homs, Janet Baack Kukreja
BJUI Compass|April 27, 2022
Use of metallic and polymeric ureteral stents in malignant ureteral obstructionMari Ohtaka, Takashi Kawahara, Yutaro Hayashi, et al.
BJUI Compass|April 27, 2022
Pediatric robotic-assisted laparoscopic ureterocalycostomy: Salient tips and technical modifications for optimal repairB L Adamic, A Lombardo, C Andolfi, et al.
BJUI Compass|April 27, 2022
Performance of prostate health index and PSA density in a diverse biopsy-naïve cohort with mpMRI for detecting significant prostate cancerSamuel Carbunaru, James Stinson, Rilwan Babajide, et al.
BJUI Compass|April 27, 2022
Quality and readability of online patient information on treatment for erectile dysfunctionTrent A Pattenden, Rachael A Raleigh, Elle R Pattenden, et al.
BJUI Compass|April 27, 2022
Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men with prostate cancerJoseph F Renzulli, Scott T Tagawa, Stuart N Atkinson, et al.
BJUI Compass|April 27, 2022
Adapting to the long pandemicJohn W Davis
BJUI Compass|April 27, 2022
Mortality in men with castration-resistant prostate cancer-A long-term follow-up of a population-based real-world cohortYashar Khoshkar, Marcus Westerberg, Jan Adolfsson, et al.
BJUI Compass|April 27, 2022
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinomaKai Ozaki, Shingo Hatakeyama, Toshikazu Tanaka, et al.
Pageof 65

Showing results (331-340 of 642) with videos related to

Sort By:
Pageof 65
BJUI Compass|February 19, 2024
Reliability of the IDENTIFY calculator in stratifying risk of urothelial carcinoma in patients with haematuria: An initial evaluation at an Australian centrePaul M Rival, Lucas Ooi, Hyun Lim, et al.
BJUI Compass|April 27, 2022
Bladder cancer biomarkers: Past and future directionsMiguel Rodriguez-Homs, Janet Baack Kukreja
BJUI Compass|April 27, 2022
Use of metallic and polymeric ureteral stents in malignant ureteral obstructionMari Ohtaka, Takashi Kawahara, Yutaro Hayashi, et al.
BJUI Compass|April 27, 2022
Pediatric robotic-assisted laparoscopic ureterocalycostomy: Salient tips and technical modifications for optimal repairB L Adamic, A Lombardo, C Andolfi, et al.
BJUI Compass|April 27, 2022
Performance of prostate health index and PSA density in a diverse biopsy-naïve cohort with mpMRI for detecting significant prostate cancerSamuel Carbunaru, James Stinson, Rilwan Babajide, et al.
BJUI Compass|April 27, 2022
Quality and readability of online patient information on treatment for erectile dysfunctionTrent A Pattenden, Rachael A Raleigh, Elle R Pattenden, et al.
BJUI Compass|April 27, 2022
Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men with prostate cancerJoseph F Renzulli, Scott T Tagawa, Stuart N Atkinson, et al.
BJUI Compass|April 27, 2022
Adapting to the long pandemicJohn W Davis
BJUI Compass|April 27, 2022
Mortality in men with castration-resistant prostate cancer-A long-term follow-up of a population-based real-world cohortYashar Khoshkar, Marcus Westerberg, Jan Adolfsson, et al.
BJUI Compass|April 27, 2022
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinomaKai Ozaki, Shingo Hatakeyama, Toshikazu Tanaka, et al.
Pageof 65